Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study

American Journal of Obstetrics and Gynecology

Volumn 185, Issue 2, 2001, Pages 380-385

  Baeten, Jared M ^a   Nyange, Patrick M ^b   Richardson, Barbra A ^a   Lavreys, Ludo ^a   Chohan, Bhavna ^b   Martin Jr, Harold L ^a,d   Mandaliya, Kishorchandra ^c   Ndinya Achola, Jeckoniah O ^b   Bwayo, Job J ^b   Kreiss, Joan K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d PARK NICOLLET CLINIC   (United States)

Author keywords

Bacterial vaginosis; Chlamydia; Hormonal contraception; Sexually transmitted diseases; Vaginal candidiasis

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; CONDOM; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROSTITUTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINITIS;

EID: 17944367295     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.115862     Document Type: Article

References (25)

1. Advances in control of sexually transmitted diseases in developing countries
2. Global prevalence and incidence estimates of selected curable STDs
3. Nonbarrier contraceptives and vaginitis and vaginosis
4. Chlamydia trachomatis and oral contraceptive use: A quantitative review
5. Contraception and sexually transmitted diseases: Interactions and opportunities
6. Women, contraception and STDs including HIV
7. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1
8. Cox's regression model for counting processes: A large sample study
9. Depot-medroxyprogesterone acetate as a contraceptive agent: Return of fertility after discontinuation of use
10. Conception delay after oral contraceptive use: The effect of estrogen dose
11. Oral contraceptive use and the risk of chlamydial and gonococcal infections
12. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis
13. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers
14. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya
15. Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials
16. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes: A randomized clinical trial
17. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease: A word of caution about protection
18. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use
19. Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones
20. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: A prospective study
21. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
22. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV
23. Contraception, contraceptive technology, and STDs